论文部分内容阅读
目的探索治疗小儿过敏性紫癜(HSP)最佳方案。方法在对症治疗基础上,采用丹参加普鲁卡因静滴联合西米替叮口服治疗小儿过敏性紫癜60例,并将其疗效与以往治疗方法作对比分析。结果丹参加普鲁卡因治疗的疗效明显优于原始治疗方法,有效率91.66%,平均住院时间为(11.08±2.20)天,与原始治疗方法比较有减少,经统计学处理有显著性差异。结论本治疗方法对小儿过敏性紫癜有明显疗效,且治疗方便,价格低廉,未发现毒副作用,适于基层医疗单位推广应用。
Objective To explore the best treatment for children with Henoch-Schonlein purpura (HSP). Methods On the basis of symptomatic treatment, 60 cases of allergic purpura in children were treated with Danshen plus procaine intravenously in combination with cimetidine orally, and its efficacy was compared with the previous treatment. Results Salvia plus procaine treatment was significantly better than the original treatment, the effective rate was 91.66%, the average length of stay was (11.08 ± 2.20) days, compared with the original treatment decreased, statistically significant difference. Conclusion The treatment of children with Henoch-Schonlein purpura has obvious curative effect, and the treatment is convenient, the price is low, no toxic or side effect is found, which is suitable for the popularization and application of primary medical units.